Enhancer for antibody to lymphocytic tumors

Enhancer for antibody to lymphocytic tumors

  • CN 101,073,667 A
  • Filed: 10/14/1998
  • Published: 11/21/2007
  • Est. Priority Date: 10/14/1997
  • Status: Abandoned Application
First Claim
Patent Images

1. the biological respinse modifier that is selected from interferon, OK432, lentinan, Sizofiran, Gastric inhibitory polypeptide, krestin, N-CWS, levamisole, G-CSF, IL-2, IL-10, IL-12 or IL-15 is used for the treatment of the purposes of lymphocyte tumor, wherein said biological respinse modifier strengthens the cytotoxicity that the energy specific bond has the proteinic antibody of aminoacid sequence shown in SEQ ID NO:

  • 5, and wherein said antibody is used for the treatment of the lymphocyte tumor.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×